<?xml version="1.0" encoding="UTF-8"?>
<ref id="b17-1030717">
 <label>17.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Drobyski</surname>
    <given-names>WR</given-names>
   </name>
   <name>
    <surname>Pasquini</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Kovatovic</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tocilizumab for the treatment of steroid refractory graft versus host disease</article-title>. 
  <source>Biol Blood Marrow Transplant</source>. 
  <year>2011</year>;
  <volume>17</volume>(
  <issue>12</issue>):
  <fpage>1862</fpage>â€“
  <lpage>1868</lpage>.
  <pub-id pub-id-type="pmid">21745454</pub-id>
 </mixed-citation>
</ref>
